Health
Cytokinetics Jumps After Report of Takeover Interest
This article is for subscribers only.
Shares of Cytokinetics Inc. jumped the most in more than two years after a report that two large drugmakers are considering buying the biotech firm.
The company is seeing takeover interest from Novartis AG and AstraZeneca Plc, according to Dealreporter. The South San Francisco-based company has attracted interest from at least one major drugmaker in recent months, Bloomberg News reported in October.